Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pulmonx (LUNG) Return on Sales (2019 - 2025)

Pulmonx (LUNG) has disclosed Return on Sales for 7 consecutive years, with 0.65% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Sales rose 5.0% to 0.65% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.62%, a 10.0% increase, with the full-year FY2024 number at 0.67%, up 21.0% from a year prior.
  • Return on Sales was 0.65% for Q3 2025 at Pulmonx, down from 0.64% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 0.55% in Q4 2024 to a low of 1.47% in Q1 2022.
  • A 5-year average of 0.89% and a median of 0.85% in 2023 define the central range for Return on Sales.
  • Biggest YoY gain for Return on Sales was 218bps in 2021; the steepest drop was -53bps in 2021.
  • Pulmonx's Return on Sales stood at 0.95% in 2021, then grew by 2bps to 0.93% in 2022, then rose by 22bps to 0.72% in 2023, then grew by 23bps to 0.55% in 2024, then decreased by -17bps to 0.65% in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Return on Sales are 0.65% (Q3 2025), 0.64% (Q2 2025), and 0.64% (Q1 2025).